A protein made by stressed cancer cells helps lung and pancreatic tumors evade the immune system, a new study shows.

Two of our faculty, Lalita Shevde-Samant, Ph.D., and Rajeev Samant, Ph.D., Ph.D., both professors in the Division of Molecular & Cellular Pathology and senior scientists, cancer cell biology with the ...

Led by researchers from NYU Langone Health, the work found that new drugs designed to block the action of a protein called ...

Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center uncovered new evidence that extra copies of a ...

Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the ...

Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...

Scientists from the University of Geneva and the Ludwig Institute for Cancer Research have learned that neutrophil immune cells can promote the growth of cancer cells rather than stop the progression ...

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...

Yale researchers have developed a machine learning model, called Immunostruct, that can help scientists create more personalized vaccines, including vaccines for cancer. They described the tool in ...